ENTITY

Bone Biologics (BBLG US)

12
Analysis
Health Care • United States
Bone Biologics Corporation operates as a biotechnology company. The Company focuses on bone regeneration in human lumbar spinal fusion using recombinant human protein growth factor. Bone Biologics offers bone repair and regeneration applications in the United States.
more
bullish•Bone Biologics
•16 May 2026 00:00•Issuer-paid

BBLG: Cash Solid as Critical Testing Continues

Bone Biologics is pursuing a better and more effective way of dealing with back pain requiring surgery by developing bone regeneration in spinal...

Share
bullish•Bone Biologics
•04 Mar 2026 03:00•Issuer-paid

BBLG: Annual Report Shows Company Well Positioned

Bone Biologics is pursuing a better and more effective way of dealing with back pain requiring surgery by developing bone regeneration in spinal...

Share
bullish•Bone Biologics
•26 Feb 2026 01:00•Issuer-paid

BBLG: At a Crucial Inflection Point

Bone Biologics is pursuing a better and more effective way of dealing with back pain requiring surgery by developing bone regeneration in spinal...

Share
bullish•Bone Biologics
•18 Nov 2025 02:00•Issuer-paid

BBLG: Cash on Hand to Fuel Commercialization Drive

Bone Biologics is pursuing a better and more effective way of dealing with back pain requiring surgery by developing bone regeneration in spinal...

Share
bullish•Bone Biologics
•16 Aug 2025 00:00•Issuer-paid

BBLG: Making Major Step Toward Commercialization

Bone Biologics is pursuing a better and more effective way of dealing with back pain requiring surgery by developing bone regeneration in spinal...

Share
x